Maximizing response to intratumoral immunotherapy in mice by tuning local retention
Abstract
Direct injection of therapies into tumors has emerged as an administration route capable of achieving high local drug exposure and strong anti-tumor response. A diverse array of immune agonists ranging in size and target are under development as local immunotherapies. However, due to the relatively recent adoption of intratumoral administration, the pharmacokinetics of locally-injected biologics remains poorly defined, limiting rational design of tumor-localized immunotherapies. Here we define a pharmacokinetic framework for biologics injected intratumorally that can predict tumor exposure and effectiveness. We find empirically and computationally that extending the tumor exposure of locally-injected interleukin-2 by increasing molecular size and/or improving matrix-targeting affinity improves therapeutic efficacy in mice. By tracking the distribution of intratumorally-injected proteins using positron emission tomography, we observe size-dependent enhancement in tumor exposure occurs by slowing the rate of diffusive escape from the tumor and by increasing partitioning to an apparent viscous region of the tumor. In elucidating how molecular weight and matrix binding interplay to determine tumor exposure, our model can aid in the design of intratumoral therapies to exert maximal therapeutic effect.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 10, 2022
- Source ID
- 10.1038/s41467-021-27390-6
Entities
People
- Anthony Tabet
- Byong H Kang
- Emi A Lutz
- Howard H. Mak
- Joseph R Palmeri
- K. Dane Wittrup
- Magnolia M Chinn
- Noor Jailkhani
- Noor Momin
- Richard O. Hynes
- Virginia Spanoudaki
Organizations
- Division of Cancer Epidemiology and Genetics, National Cancer Institute
- Division of Graduate Education
- National Science Foundation Directorate for Education and Human Resources
- Paul & Daisy Soros Fellowships for New Americans
- United States Department of Defense
- United States Department of Health and Human Services